Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Equity (2016 - 2025)

Historic Return on Equity for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to 0.01%.

  • Aytu Biopharma's Return on Equity rose 500.0% to 0.01% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.01%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.03% for FY2025, which is 1300.0% up from last year.
  • According to the latest figures from Q4 2025, Aytu Biopharma's Return on Equity is 0.01%, which was up 500.0% from 0.01% recorded in Q3 2025.
  • Aytu Biopharma's 5-year Return on Equity high stood at 0.02% for Q2 2025, and its period low was 2.06% during Q2 2022.
  • For the 5-year period, Aytu Biopharma's Return on Equity averaged around 0.57%, with its median value being 0.39% (2021).
  • In the last 5 years, Aytu Biopharma's Return on Equity tumbled by -16500bps in 2022 and then surged by 16400bps in 2023.
  • Aytu Biopharma's Return on Equity (Quarter) stood at 0.77% in 2021, then plummeted by -112bps to 1.63% in 2022, then soared by 79bps to 0.35% in 2023, then surged by 87bps to 0.04% in 2024, then skyrocketed by 114bps to 0.01% in 2025.
  • Its Return on Equity was 0.01% in Q4 2025, compared to 0.01% in Q3 2025 and 0.02% in Q2 2025.